MedPath

CERETEC

Ceretec™ N109A Kit for the Preparation of Technetium Tc99m Exametazime Injection

Approved
Approval ID

3c1eca7e-57a0-4876-8ed6-cd655ef5e296

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 10, 2024

Manufacturers
FDA

Medi-Physics Inc. dba GE Healthcare.

DUNS: 095263729

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

TECHNETIUM TC-99M EXAMETAZIME

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code17156-022
Application NumberNDA019829
Product Classification
M
Marketing Category
C73594
G
Generic Name
TECHNETIUM TC-99M EXAMETAZIME
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 1, 2018
FDA Product Classification

INGREDIENTS (4)

TECHNETIUM TC-99M EXAMETAZIMEActive
Quantity: 0.5 mg in 5 mL
Code: 3B744AG22N
Classification: ACTIR
Stannous ChlorideInactive
Quantity: 7.6 ug in 5 mL
Code: 1BQV3749L5
Classification: IACT
NitrogenInactive
Code: N762921K75
Classification: IACT
Sodium ChlorideInactive
Quantity: 4.0 mg in 5 mL
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CERETEC - FDA Drug Approval Details